van Bodegraven AA - Search Results

1

Genetic variation in myosin IXB is associated with ulcerative colitis.

van Bodegraven AA, Curley CR, Hunt KA, Monsuur AJ, Linskens RK, Onnie CM, Crusius JB, Annese V, Latiano A, Silverberg MS, Bitton A, Fisher SA, Steinhart AH, Forbes A, Sanderson J, Prescott NJ, Strachan DP, Playford RJ, Mathew CG, Wijmenga C, Daly MJ, Rioux JD, van Heel DA. van Bodegraven AA, et al. Among authors: van heel da. Gastroenterology. 2006 Dec;131(6):1768-74. doi: 10.1053/j.gastro.2006.09.011. Epub 2006 Sep 8. Gastroenterology. 2006. PMID: 17087940

2

Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease.

Van Bodegraven AA, Tuynman HA, Schoorl M, Kruishoop AM, Bartels PC. Van Bodegraven AA, et al. Scand J Gastroenterol. 1995 Jun;30(6):580-5. doi: 10.3109/00365529509089793. Scand J Gastroenterol. 1995. PMID: 7569767

3

Addition of low-dose oral cyclosporine in severe ulcerative colitis--pharmacokinetics and clinical outcome report of twelve cases.

van Bodegraven AA, Linskens RK, van Haelst IM, Sindram JW, Tuynman HA. van Bodegraven AA, et al. Among authors: van haelst im. J Clin Gastroenterol. 1998 Jul;27(1):72-3. doi: 10.1097/00004836-199807000-00015. J Clin Gastroenterol. 1998. PMID: 9706775 No abstract available.

4

Serum eosinophil cationic protein in active and quiescent ulcerative colitis.

Pronk-Admiraal CJ, Linskens RK, Van Bodegraven AA, Tuynman HA, Bartels PC. Pronk-Admiraal CJ, et al. Among authors: van bodegraven aa. Clin Chem Lab Med. 2000 Jul;38(7):619-22. doi: 10.1515/CCLM.2000.090. Clin Chem Lab Med. 2000. PMID: 11028767

5

Hemostatic imbalance in active and quiescent ulcerative colitis.

van Bodegraven AA, Schoorl M, Baak JP, Linskens RK, Bartels PC, Tuynman HA. van Bodegraven AA, et al. Am J Gastroenterol. 2001 Feb;96(2):487-93. doi: 10.1111/j.1572-0241.2001.03532.x. Am J Gastroenterol. 2001. PMID: 11232695

6

Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Linskens RK, van Bodegraven AA, Schoorl M, Tuynman HA, Bartels P. Linskens RK, et al. Among authors: van bodegraven aa. Dig Dis Sci. 2001 Mar;46(3):644-8. doi: 10.1023/a:1005628005734. Dig Dis Sci. 2001. PMID: 11318546

7

Lipoprotein (a), thrombophilia and inflammatory bowel disease.

van Bodegraven AA, Meuwissen SG. van Bodegraven AA, et al. Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1407-9. doi: 10.1097/00042737-200112000-00002. Eur J Gastroenterol Hepatol. 2001. PMID: 11742187 Review.

8

A functional interleukin-10 mutation in Dutch patients with Crohn's disease.

van der Linde K, Boor PP, van Bodegraven AA, de Jong DJ, Crusius JB, Naber TH, Kuipers EJ, Wilson JH, de Rooij FW. van der Linde K, et al. Among authors: van bodegraven aa. Dig Liver Dis. 2005 May;37(5):330-5. doi: 10.1016/j.dld.2004.12.009. Dig Liver Dis. 2005. PMID: 15843082

9

A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.

Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G. Borm ME, et al. Among authors: van bodegraven aa. Int J Immunogenet. 2005 Dec;32(6):401-5. doi: 10.1111/j.1744-313X.2005.00546.x. Int J Immunogenet. 2005. PMID: 16313306

10

6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child.

de Boer NK, Van Elburg RM, Wilhelm AJ, Remmink AJ, Van Vugt JM, Mulder CJ, Van Bodegraven AA. de Boer NK, et al. Among authors: van bodegraven aa, van vugt jm, van elburg rm. Scand J Gastroenterol. 2005 Nov;40(11):1374-7. doi: 10.1080/00365520510024089. Scand J Gastroenterol. 2005. PMID: 16334449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page